COSCIENS Biopharma Inc.
(MENAFN- Baystreet) 10:09 AM EST - COSCIENS Biopharma Inc.: Announced the publication of a new corporate presentation, now available on its website at The presentation provides an overview of the Company and its operating subsidiaries, following the recent acquisition of Nualtis Corp. and includes information relating to the ongoing private placement of 15% unsecured convertible debentures. COSCIENS Biopharma Inc.
shares T are trading unchanged at $9.16.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment